Literature DB >> 17151094

Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus.

Noriyo Nagata1, Naoko Iwata, Hideki Hasegawa, Shuetsu Fukushi, Masaru Yokoyama, Ayako Harashima, Yuko Sato, Masayuki Saijo, Shigeru Morikawa, Tetsutaro Sata.   

Abstract

To understand the pathogenesis and develop an animal model of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV), the Frankfurt 1 SARS-CoV isolate was passaged serially in young F344 rats. Young rats were susceptible to SARS-CoV but cleared the virus rapidly within 3 to 5 days of intranasal inoculation. After 10 serial passages, replication and virulence of SARS-CoV were increased in the respiratory tract of young rats without clinical signs. By contrast, adult rats infected with the passaged virus showed respiratory symptoms and severe pathological lesions in the lung. Levels of inflammatory cytokines in sera and lung tissues were significantly higher in adult F344 rats than in young rats. During in vivo passage of SARS-CoV, a single amino acid substitution was introduced within the binding domain of the viral spike protein recognizing angiotensin-converting enzyme 2 (ACE2), which is known as a SARS-CoV receptor. The rat-passaged virus more efficiently infected CHO cells expressing rat ACE2 than did the original isolate. These results strongly indicate that host and virus factors such as advanced age and virus adaptation are critical for the development of SARS in rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151094      PMCID: PMC1797583          DOI: 10.1128/JVI.01967-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Force fields for protein simulations.

Authors:  Jay W Ponder; David A Case
Journal:  Adv Protein Chem       Date:  2003

2.  Analysis of serum cytokines in patients with severe acute respiratory syndrome.

Authors:  Yuanchun Zhang; Jing Li; Yuliang Zhan; Lianqiu Wu; Xueying Yu; Wenjian Zhang; Liya Ye; Shiqing Xu; Ruihua Sun; Yunting Wang; Jinning Lou
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

3.  Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.

Authors:  Wenhui Li; Thomas C Greenough; Michael J Moore; Natalya Vasilieva; Mohan Somasundaran; John L Sullivan; Michael Farzan; Hyeryun Choe
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  Macaque model for severe acute respiratory syndrome.

Authors:  Thomas Rowe; Guangping Gao; Robert J Hogan; Ronald G Crystal; Thomas G Voss; Rebecca L Grant; Peter Bell; Gary P Kobinger; Nelson A Wivel; James M Wilson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys.

Authors:  Josephine McAuliffe; Leatrice Vogel; Anjeanette Roberts; Gary Fahle; Steven Fischer; Wun-Ju Shieh; Emily Butler; Sherif Zaki; Marisa St Claire; Brian Murphy; Kanta Subbarao
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

6.  Susceptibility of pigs and chickens to SARS coronavirus.

Authors:  Hana M Weingartl; John Copps; Michael A Drebot; Peter Marszal; Greg Smith; Jason Gren; Maya Andova; John Pasick; Paul Kitching; Markus Czub
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

7.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

8.  Lung pathology of fatal severe acute respiratory syndrome.

Authors:  John M Nicholls; Leo L M Poon; Kam C Lee; Wai F Ng; Sik T Lai; Chung Y Leung; Chung M Chu; Pak K Hui; Kong L Mak; Wilina Lim; Kin W Yan; Kwok H Chan; Ngai C Tsang; Yi Guan; Kwok Y Yuen; J S Malik Peiris
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

9.  Effects of a SARS-associated coronavirus vaccine in monkeys.

Authors:  Wentao Gao; Azaibi Tamin; Adam Soloff; Leonardo D'Aiuto; Edward Nwanegbo; Paul D Robbins; William J Bellini; Simon Barratt-Boyes; Andrea Gambotto
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

10.  Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

Authors:  Alexander Bukreyev; Elaine W Lamirande; Ursula J Buchholz; Leatrice N Vogel; William R Elkins; Marisa St Claire; Brian R Murphy; Kanta Subbarao; Peter L Collins
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

View more
  30 in total

1.  T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice.

Authors:  Jincun Zhao; Jingxian Zhao; Stanley Perlman
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

2.  Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.

Authors:  Gregory A Zornetzer; Matthew B Frieman; Elizabeth Rosenzweig; Marcus J Korth; Carly Page; Ralph S Baric; Michael G Katze
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo.

Authors:  Susanne Pfefferle; Verena Krähling; Vanessa Ditt; Klaus Grywna; Elke Mühlberger; Christian Drosten
Journal:  Virol J       Date:  2009-08-24       Impact factor: 4.099

4.  Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.

Authors:  Jason Netland; Marta L DeDiego; Jincun Zhao; Craig Fett; Enrique Álvarez; José L Nieto-Torres; Luis Enjuanes; Stanley Perlman
Journal:  Virology       Date:  2010-01-27       Impact factor: 3.616

5.  Exacerbated innate host response to SARS-CoV in aged non-human primates.

Authors:  Saskia L Smits; Anna de Lang; Judith M A van den Brand; Lonneke M Leijten; Wilfred F van IJcken; Marinus J C Eijkemans; Geert van Amerongen; Thijs Kuiken; Arno C Andeweg; Albert D M E Osterhaus; Bart L Haagmans
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

6.  Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease.

Authors:  Christine L Wohlford-Lenane; David K Meyerholz; Stanley Perlman; Haixia Zhou; Dat Tran; Michael E Selsted; Paul B McCray
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

7.  Genetic and biological characterization of tick-borne encephalitis virus isolated from wild rodents in southern Hokkaido, Japan in 2008.

Authors:  Yoshii Kentaro; Shoko Yamazaki; Keita Mottate; Noriyo Nagata; Takahiro Seto; Takashiro Sanada; Mizuki Sakai; Hiroaki Kariwa; Ikuo Takashima
Journal:  Vector Borne Zoonotic Dis       Date:  2013-04-16       Impact factor: 2.133

Review 8.  Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.

Authors:  Rudragouda Channappanavar; Stanley Perlman
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

9.  A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.

Authors:  Craig W Day; Ralph Baric; Sui Xiong Cai; Matt Frieman; Yohichi Kumaki; John D Morrey; Donald F Smee; Dale L Barnard
Journal:  Virology       Date:  2009-10-22       Impact factor: 3.616

Review 10.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.